IRIS Accounts Production v24.2.0.383 08015160 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080151602023-03-31080151602024-03-31080151602023-04-012024-03-31080151602022-03-31080151602022-04-012023-03-31080151602023-03-3108015160ns15:EnglandWales2023-04-012024-03-3108015160ns14:PoundSterling2023-04-012024-03-3108015160ns10:Director12023-04-012024-03-3108015160ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108015160ns10:SmallEntities2023-04-012024-03-3108015160ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108015160ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3108015160ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108015160ns10:FullAccounts2023-04-012024-03-310801516012023-04-012024-03-3108015160ns10:OrdinaryShareClass12023-04-012024-03-3108015160ns10:Director22023-04-012024-03-3108015160ns10:Director42023-04-012024-03-3108015160ns10:Director52023-04-012024-03-3108015160ns10:RegisteredOffice2023-04-012024-03-3108015160ns5:CurrentFinancialInstruments2024-03-3108015160ns5:CurrentFinancialInstruments2023-03-3108015160ns5:ShareCapital2024-03-3108015160ns5:ShareCapital2023-03-3108015160ns5:RetainedEarningsAccumulatedLosses2024-03-3108015160ns5:RetainedEarningsAccumulatedLosses2023-03-3108015160ns5:NetGoodwill2023-04-012024-03-3108015160ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108015160ns5:NetGoodwill2023-03-3108015160ns5:NetGoodwill2024-03-3108015160ns5:NetGoodwill2023-03-3108015160ns5:MotorVehicles2023-03-3108015160ns5:ComputerEquipment2023-03-3108015160ns5:MotorVehicles2023-04-012024-03-3108015160ns5:ComputerEquipment2023-04-012024-03-3108015160ns5:MotorVehicles2024-03-3108015160ns5:ComputerEquipment2024-03-3108015160ns5:MotorVehicles2023-03-3108015160ns5:ComputerEquipment2023-03-3108015160ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108015160ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3108015160ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 08015160 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

DR MASOOD KHAN LIMITED

DR MASOOD KHAN LIMITED (REGISTERED NUMBER: 08015160)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DR MASOOD KHAN LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2024







DIRECTORS: Mrs A Khan
Dr M A Khan
Mr Z A Khan
Mr H A Khan





REGISTERED OFFICE: 100 Barbirolli Square
Manchester
M2 3BD





REGISTERED NUMBER: 08015160 (England and Wales)





ACCOUNTANTS: Xeinadin
100 Barbirolli Square
Manchester
M2 3BD

DR MASOOD KHAN LIMITED (REGISTERED NUMBER: 08015160)

BALANCE SHEET
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 14,400 17,845
14,400 17,845

CURRENT ASSETS
Debtors 6 23,009 27,069
Cash at bank 153,797 121,902
176,806 148,971
CREDITORS
Amounts falling due within one year 7 23,089 20,222
NET CURRENT ASSETS 153,717 128,749
TOTAL ASSETS LESS CURRENT
LIABILITIES

168,117

146,594

PROVISIONS FOR LIABILITIES 3,600 4,461
NET ASSETS 164,517 142,133

CAPITAL AND RESERVES
Called up share capital 8 2 2
Retained earnings 164,515 142,131
SHAREHOLDERS' FUNDS 164,517 142,133

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DR MASOOD KHAN LIMITED (REGISTERED NUMBER: 08015160)

BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 November 2024 and were signed on its behalf by:





Dr M A Khan - Director


DR MASOOD KHAN LIMITED (REGISTERED NUMBER: 08015160)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

Dr Masood Khan Limited is a private company limited by share capital, incorporated in England and Wales, registration number 08015160. The address of the registered office is 100 Barbirolli Square, Manchester, M2 3BD. The principal place of business is 114 Rowlands Avenue, Pinner, Middlesex, HA5 4AP

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts recognised by the company in respect of services supplied, exclusive of Value Added Tax and trade discounts. Turnover principally consists of fees for the provision of medical services, which are recognised at the point at which the services are provided.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Depreciation on fixed assets is charged to the profit and loss so as to write off their value, over their estimated useful lives, using the following methods:

Motor vehicles - 20% on reducing balance
Computer equipment - 20% on cost

At each balance sheet date, the company reviews the carrying amounts of its fixed assets to determine whether there is any indication that any items of property, plant and equipment have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. Impairment loss is recognised as an expense immediately.

Taxation
Taxation for the year comprises current tax. Tax is recognised in the profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DR MASOOD KHAN LIMITED (REGISTERED NUMBER: 08015160)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued

Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand.

Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case they are stated at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 20,000
AMORTISATION
At 1 April 2023
and 31 March 2024 20,000
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

5. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 April 2023 40,490 5,330 45,820
Additions - 365 365
At 31 March 2024 40,490 5,695 46,185
DEPRECIATION
At 1 April 2023 23,905 4,070 27,975
Charge for year 3,317 493 3,810
At 31 March 2024 27,222 4,563 31,785
NET BOOK VALUE
At 31 March 2024 13,268 1,132 14,400
At 31 March 2023 16,585 1,260 17,845

DR MASOOD KHAN LIMITED (REGISTERED NUMBER: 08015160)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 23,009 21,364
Other debtors - 5,705
23,009 27,069

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 19,191 17,049
Other creditors 3,898 3,173
23,089 20,222

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Included in other debtors is a balance owing from the directors of £557 (2023 - £557).